About Episona
Episona is a Healthcare company based in Los Angeles (United States) founded in 2013. It operates as a male infertility is diagnosed through epigenetic analysis of sperm samples. Episona has raised $4 million across 1 funding round from investors including Pasadena Angels. Episona offers products and services including SpermQT. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Inherent Biosciences, Inc. Its competitors include Everlywell, Viome, Helix, Color and Invitae and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
Episona is a digital health company connecting epigenetic abnormalities and human disease. First product, Episonas Seed, a diagnostic test for testing male infertility based on pattern variations found in the sperm epigenome. User collects his sample at home and ship directly to their CLIA certified lab. The postage is pre-paid. Provides easy-to-understand results online. Claims to keep data secure.
- Headquarters Los Angeles, United States
- SectorsHealthcare
- Website episona.com
- Social LinkedIn X Facebook
- Legal Name Inherent Biosciences, Inc.
- Total Equity Funding$4M (USD)
in 1 rounds
- Latest Funding Round$4M (USD), Seed
Jun 2017
- Investors
Products & Services of Episona
Episona offers a comprehensive portfolio of products and services, including SpermQT.
Assesses sperm ability to fertilize an egg for better treatment choices
Funding Insights of Episona
Episona has successfully raised a total of $4M through 1 strategic funding round. The most recent funding activity was a Seed round of $4 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4M
- Total Rounds 1
- Last Round Seed — $4M
- First Round $4M
(Jun 2017)
- Investors Count 1
All 1 funding rounds of Episona with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $4M | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Episona
Episona has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Pasadena Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are facilitated by Pasadena Angels in Southern California startups. | 2000 | pasadenaangels.com | Altadena, United States |
Investor details for Episona
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Episona
2 dated milestones of Episona across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Episona is founded.
- Funding First funding round of $4.0M.
Competitors of Episona
Episona has 9 listed competitors in our database, 9 of them funded. They include Everlywell, Viome, Helix, Color and Invitae, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| arivale.com | 2014 | Seattle, United States | $49.6M | – | Provider of direct-to-consumer genetic testing. |
Detailed competitors of Episona
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Episona
Websites that share an audience with Episona (episona.com).
Websites whose visitors overlap most with Episona. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dana.org | dana.org | 100% | – | #339,301 | – |
joshgitalis.com | joshgitalis.com | 92% | – | #5,699,019 | – |
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Episona (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Episona
Complete news archive for Episona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Episona
Episona was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Episona is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Episona is a funded company, having raised a total of $4M across 1 funding round to date. The company's 1st funding round was a Seed of $4M, raised on Jun 2017.
Episona is a digital health company connecting epigenetic abnormalities and human disease. First product, Episonas Seed, a diagnostic test for testing male infertility based on pattern variations found in the sperm epigenome. User collects his sample at home and ship directly to their CLIA certified lab. The postage is pre-paid. Provides easy-to-understand results online. Claims to keep data secure.
Episona's top competitors include Viome, Helix and Variant Bio.
Episona offers SpermQT.
Episona has 1 investor. Key investors include Pasadena Angels.
Episona operates through Inherent Biosciences, Inc..